Prof. Dirk Jager

Medical Degrees

• Medical Studies (Graduation) — Universities of Lübeck and Freiburg, Germany, 1985–1991
• Practical Year — Karlsruhe Municipal Hospital, Germany
• Doctorate (Dr. med. / MD) — Germany
• Habilitation in Internal Medicine — Mainz University Clinic, 2003
• Professor (Univ.-Prof.) of Medical Oncology — Medical Faculty, Heidelberg University

Fellowships & Special Training

• Two-year Research Fellowship — Cancer Research Institute (CRI), New York City, USA
• Specialist Examination for Internal Medicine, 1998
• Recognition of Specialisation in Haematology and Internal Oncology, 2003

Certifications & Accreditations

• Board Certification in Internal Medicine — Germany
• Board Certification in Haematology and Oncology — Germany
• Baden-Württemberg State Medical Council — Registered Specialist
• Member, Cancer Vaccine Collaborative — CRI & Ludwig Institute for Cancer Research, New York

Current Affiliation

• Medical Director — Department of Medical Oncology (Medical Clinic VI), Heidelberg University Hospital (UKHD) (Present)
• Managing Director — National Center for Tumor Diseases (NCT) Heidelberg (since 1 July 2005 – Present)
• Head, Clinical Cooperation Unit “Applied Tumor Immunity” — German Cancer Research Center (DKFZ), Heidelberg (since 2013 – Present)
• Head, NCT Program “Immunotherapy” — NCT Heidelberg (Present)
• Board Member — NCT Heidelberg Comprehensive Cancer Center (Present)
• Univ.-Prof. of Medical Oncology — Medical Faculty Heidelberg, Heidelberg University (Present)

Past Affiliations

• Mainz University Clinic — Habilitation in Internal Medicine, 2003
• Cancer Research Institute (CRI), New York City, USA — Research Fellow, 2-year fellowship
• Karlsruhe Municipal Hospital, Germany — Practical Year
• Universities of Lübeck and Freiburg, Germany — Medical Studies, 1985–1991

Academic & Research Roles

• Univ.-Prof. of Medical Oncology — Medical Faculty Heidelberg
• Member, Clinical Leadership Committee — Cancer Research Institute (CRI), New York
• Affiliate / Partner — Cancer Vaccine Collaborative and Ludwig Institute for Cancer Research, New York
• Author of multiple high-impact peer-reviewed publications in cancer immunotherapy and translational oncology
• Active mentor for clinician-scientists and PhD candidates at NCT Heidelberg / DKFZ

Key Achievements

• Founding Managing Director of NCT Heidelberg — one of Europe’s leading comprehensive cancer centres
• Pioneered translation of immunotherapies into early-phase clinical trials in Germany
• Built the Clinical Cooperation Unit “Applied Tumor Immunity” at DKFZ
• Affiliate of the Ludwig Institute for Cancer Research and Cancer Vaccine Collaborative, New York